Tumor Ablation - Global Market Outlook (2018-2027)

   |      |      |  

Tumor Ablation - Global Market Outlook (2018-2027)

"The Global Tumor Ablation Market is accounted for $394.66 million in 2018 and is expected to reach $1,253.33 million by 2027 growing at a CAGR of 13.7% during the forecast period. Some of the key factors influencing the market growth include technological advancements in the thermal ablation techniques, growing geriatric population across the world, increasing incidence of cancer and sprouting number of hospitals, surgical, and ablation centres. However, the strict regulatory process is restraining market growth.

Tumor ablation is a minimally invasive image-guided technique used in the treatment of the tumors in the liver, kidney, soft tissue and bone. It ensures high efficacy of tumor treatment with minimal side effects by using heat, chemicals and low temperature. It uses an array of parallel alternating electrodes to deliver radiofrequency energy that heats the lining of the gastrointestinal tract, destroying the cancerous or infected tissue. Tumor ablation has primarily been used for the treatment of oesophagal squamous cell dysplasia, gastric antral vascular ectasia, radiation proctopathy, cholangiocarcinoma, and pancreatic neoplasia.

Based on the technology, radiofrequency ablation system (RFA) is expected to grow at a significant rate during the forecast period, due to its ease of treatment (as compared to open surgical procedure), its proven clinical efficacy and safety profile, and ongoing developments & commercialization of technologically advanced radiofrequency tumor ablation systems. Radiofrequency ablation uses high-energy radio waves for treatment, in which a thin, needle-like probe is inserted into the tumor. RFA is more effective in hepatocellular carcinoma (HCC), the most common primary liver neoplasia with a poor diagnosis.

By geography, North America is likely to have a huge demand owing to high prevalence and incidence of major types of cancer (such as liver, lung, kidney, and bone metastasis) in the region, rising inclination of patients towards minimally invasive procedures for cancer treatment, and increasing government funding for cancer research. The growing investments of many key players in this market have grown significantly in the United States. Besides, the focus on the development of products with innovative features and greater effectiveness has increased in recent times. As a result, there has been a rise in R&D funds.

Some of the key players in global tumor ablation market are INTIO Inc., Medtronic PLC, Galil Medical, Inc., Sonacare Medical, AngioDynamics, Inc., NeuWave Medical, EDAP TMS S.A., Healthtronics, Inc., Ethicon, Inc., Koninklijke Philips N.V, Misonix, Inc., IceCure Medical Ltd., Boston Scientific Corporation, ERBE Elektromedizin GmbH, CooperSurgical Inc., Mermaid Medical, Endocare Inc., and B V M Meditech Private Limited.

Treatments Covered:
• Laparoscopic ablation
• Surgical ablation
• Percutaneous ablation

Functions Covered:
• Conventional ablation devices
• Automated/Robotic ablation

Technologies Covered:
• Image Guidance Products
• Tumor Ablation Systems
• Catheters or Probes

Applications Covered:
• Liver cancer
• Prostate cancer
• Lung cancer
• Breast cancer
• Kidney cancer
• Bone Metastasis
• Brain Cancer
• Pancreatic Cancer
• Pain palliation
• ENT Cancer

End Users Covered:
• Oncology Clinics
• Research Institutes
• Cancer Specialty Centers
• Hospitals
• Surgical and Ablation Centers
• Diagnostic Centres

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
"

"1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Tumor Ablation Market, By Treatment
5.1 Introduction
5.2 Laparoscopic Ablation
5.3 Surgical Ablation
5.4 Percutaneous Ablation

6 Global Tumor Ablation Market, By Function
6.1 Introduction
6.2 Conventional ablation devices
6.3 Automated\/Robotic ablation

7 Global Tumor Ablation Market, By Technology
7.1 Introduction
7.2 Image Guidance Products
7.2.1 Magnetic Resonance Imaging (MRI)
7.2.2 Computed Tomography
7.3 Tumor Ablation Systems
7.3.1 Cryoablation
7.3.2 Microwave Ablation System
7.3.3 Radiofrequency Ablation System (RFA)
7.3.4 Irreversible Electroporation Ablation
7.3.5 High Intensity Focused Ultrasound
7.3.6 Laser Interstitial Thermal Ablation
7.3.7 Hyperthermic ablation
7.4 Catheters or Probes

8 Global Tumor Ablation Market, By Application
8.1 Introduction
8.2 Liver cancer
8.3 Prostate cancer
8.4 Lung cancer
8.5 Breast cancer
8.6 Kidney cancer
8.7 Bone Metastasis
8.8 Brain Cancer
8.9 Pancreatic Cancer
8.10 Pain palliation
8.11 ENT Cancer

9 Global Tumor Ablation Market, By End User
9.1 Introduction
9.2 Oncology Clinics
9.3 Research Institutes
9.4 Cancer Specialty Centers
9.5 Hospitals
9.6 Surgical and Ablation Centers
9.7 Diagnostic Centres

10 Global Tumor Ablation Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa

11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling
12.1 INTIO Inc.
12.2 Medtronic PLC
12.3 Galil Medical, Inc.
12.4 Sonacare Medical
12.5 AngioDynamics, Inc.
12.6 NeuWave Medical
12.7 EDAP TMS S.A.
12.8 Healthtronics, Inc.
12.9 Ethicon, Inc.
12.10 Koninklijke Philips N.V
12.11 Misonix, Inc.
12.12 IceCure Medical Ltd.
12.13 Boston Scientific Corporation
12.14 ERBE Elektromedizin GmbH
12.15 CooperSurgical Inc.
12.16 Mermaid Medical
12.17 Endocare Inc.
12.18 B V M Meditech Private Limited

List of Tables
Table 1 Global Tumor Ablation Market Outlook, By Region (2017-2027) ($MN)
Table 2 Global Tumor Ablation Market Outlook, By Treatment (2017-2027) ($MN)
Table 3 Global Tumor Ablation Market Outlook, By Laparoscopic Ablation (2017-2027) ($MN)
Table 4 Global Tumor Ablation Market Outlook, By Surgical Ablation (2017-2027) ($MN)
Table 5 Global Tumor Ablation Market Outlook, By Percutaneous Ablation (2017-2027) ($MN)
Table 6 Global Tumor Ablation Market Outlook, By Function (2017-2027) ($MN)
Table 7 Global Tumor Ablation Market Outlook, By Conventional ablation devices (2017-2027) ($MN)
Table 8 Global Tumor Ablation Market Outlook, By Automated\/Robotic ablation (2017-2027) ($MN)
Table 9 Global Tumor Ablation Market Outlook, By Technology (2017-2027) ($MN)
Table 10 Global Tumor Ablation Market Outlook, By Image Guidance Products (2017-2027) ($MN)
Table 11 Global Tumor Ablation Market Outlook, By Magnetic Resonance Imaging (MRI) (2017-2027) ($MN)
Table 12 Global Tumor Ablation Market Outlook, By Computed Tomography (2017-2027) ($MN)
Table 13 Global Tumor Ablation Market Outlook, By Tumor Ablation Systems (2017-2027) ($MN)
Table 14 Global Tumor Ablation Market Outlook, By Cryoablation (2017-2027) ($MN)
Table 15 Global Tumor Ablation Market Outlook, By Microwave Ablation System (2017-2027) ($MN)
Table 16 Global Tumor Ablation Market Outlook, By Radiofrequency Ablation System (RFA) (2017-2027) ($MN)
Table 17 Global Tumor Ablation Market Outlook, By Irreversible Electroporation Ablation (2017-2027) ($MN)
Table 18 Global Tumor Ablation Market Outlook, By High Intensity Focused Ultrasound (2017-2027) ($MN)
Table 19 Global Tumor Ablation Market Outlook, By Laser Interstitial Thermal Ablation (2017-2027) ($MN)
Table 20 Global Tumor Ablation Market Outlook, By Hyperthermic ablation (2017-2027) ($MN)
Table 21 Global Tumor Ablation Market Outlook, By Catheters or Probes (2017-2027) ($MN)
Table 22 Global Tumor Ablation Market Outlook, By Application (2017-2027) ($MN)
Table 23 Global Tumor Ablation Market Outlook, By Liver cancer (2017-2027) ($MN)
Table 24 Global Tumor Ablation Market Outlook, By Prostate cancer (2017-2027) ($MN)
Table 25 Global Tumor Ablation Market Outlook, By Lung cancer (2017-2027) ($MN)
Table 26 Global Tumor Ablation Market Outlook, By Breast cancer (2017-2027) ($MN)
Table 27 Global Tumor Ablation Market Outlook, By Kidney cancer (2017-2027) ($MN)
Table 28 Global Tumor Ablation Market Outlook, By Bone Metastasis (2017-2027) ($MN)
Table 29 Global Tumor Ablation Market Outlook, By Brain Cancer (2017-2027) ($MN)
Table 30 Global Tumor Ablation Market Outlook, By Pancreatic Cancer (2017-2027) ($MN)
Table 31 Global Tumor Ablation Market Outlook, By Pain palliation (2017-2027) ($MN)
Table 32 Global Tumor Ablation Market Outlook, By ENT Cancer (2017-2027) ($MN)
Table 33 Global Tumor Ablation Market Outlook, By End User (2017-2027) ($MN)
Table 34 Global Tumor Ablation Market Outlook, By Oncology Clinics (2017-2027) ($MN)
Table 35 Global Tumor Ablation Market Outlook, By Research Institutes (2017-2027) ($MN)
Table 36 Global Tumor Ablation Market Outlook, By Cancer Specialty Centers (2017-2027) ($MN)
Table 37 Global Tumor Ablation Market Outlook, By Hospitals (2017-2027) ($MN)
Table 38 Global Tumor Ablation Market Outlook, By Surgical and Ablation Centers (2017-2027) ($MN)
Table 39 Global Tumor Ablation Market Outlook, By Diagnostic Centres (2017-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

"

Tumor Ablation - Global Market Outlook (2018-2027)

.